This inventor holds 6 USPTO granted patents and 1 published patent application. Top assignees: New York University, The State University of New York, Other. Active years: 2003-2021.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Irvine, CA (US) (2003)
- Glenmont, NY (US) (2016 - 2021)
Company Filing History:
4 out of 1,728 
4 out of 2,046 
2 out of 834,513 Years Active: 2003-2021
Title: The Innovative Contributions of Alexander Z Shekhtman
Introduction
Alexander Z Shekhtman is a prominent inventor based in Irvine, California, known for his significant contributions to the field of pharmaceutical chemistry. With a total of six patents to his name, Shekhtman has focused on developing compounds that modulate RAGE activity, which is crucial in various medical conditions.
Latest Patents
Among his latest patents, Shekhtman has developed quinoline compounds that serve as modulators of RAGE activity. These compounds are designed to be used in pharmaceutical compositions for the prevention and treatment of numerous conditions in mammals, including diabetes complications, inflammation, neurodegeneration, obesity, cancer, ischemia/reperfusion injury, and cardiovascular diseases. Additionally, he has patented amino, amido, and heterocyclic compounds that also act as modulators of RAGE activity, further expanding the potential therapeutic applications of his research.
Career Highlights
Shekhtman has had a distinguished career, working at esteemed institutions such as the State University of New York and New York University. His work has significantly advanced the understanding of RAGE-related diseases and has the potential to lead to innovative treatments.
Collaborations
Throughout his career, Shekhtman has collaborated with notable colleagues, including Ann Marie Schmidt and Ravichandran Ramasamy. These collaborations have enriched his research and contributed to the development of his patented compounds.
Conclusion
Alexander Z Shekhtman's innovative work in pharmaceutical chemistry, particularly in the modulation of RAGE activity, showcases his commitment to addressing critical health issues. His contributions through patents and collaborations highlight the importance of research in developing effective treatments for various diseases.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile